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A total of 52 acutc Ieukcmic childrcn have been safely and effectiveIy vaccinated
with live varicella (Oka strain) vaccinc given under close clinical and jinmunological
observation. The incidence of zoster in the vaccinatcd children group was slightly
less than that in the group that had experienced natural varicclla.
INTRODUCTION
From 1974 to 1976, a live vancella vaccine of
the Oka strain. (Takahashi at a1. , 1974) was
used for thc first time for 121eukemic children
(Izawa or a1. , 1977). \\11th careful considcration
of the fact that ICUkemic children are extraor-
dinarily susceptible to VZ virus infection, vac-
cination was limitcd to only those children in
a good Ieukemic and jinmunologic status.
Since that pilot study we have vaccinated a
total of 52 children with acutc Ieukcmia. This
paper TCPorts clinical and jinmunological ob-
servations on tllese children
IVIATERIALS AND METHODS
I. 11acc, ', Ie
The Oka strain of vancella \, accinc, \\. hiclt it rid
been passaged in ITUmait embryonic lung cells (HEL)
11 times, in guinea itig embryo cells (GPE) 12 times
and theIT in ITUman diploid cells (\\'I-38) 2 to 9 times,
was injected subcutaneously into eaclT patient
RESULTS
I. GIIfrical a, Id seJ'o10gi'CUI ,'espo, Ifes ajie, ' onc-
CIMttt!071
As shown in Tablc I, a total of 52 children
with acute Ieukcmia t51 with acute lympho-
blastic ICUkemia (ALL), and I with acutc
my CIOblastic leukemia (A1\IL)l were given var-
IOUs doses of vaccine virus. The serological
titcrs and clinical manifestations of 27 of thcsc
paticnts are still under observation and 12 chil-
dren were followcd up for over 5 years.
Seroconversion was observed in all the vac-
Ten of the 50 vaccinees showed a
clinical reaction; 9 developed rashes, and 4 of
these children and one other devcloped fever,
us ^I, .wn in d. tall in T, b1.2. In co^. 8 (TM. )
the rasl\ lasted for 60 days. However he had
no fever, chemotherapy was not discontinued
after the appearance of the rash, and this clini-
cal symptoms were not troublesome. In most
cases serum antibody, titers were measured by
cinees.
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the neutralization test, but some were deter-
mined by CF and FAAIA tests. The results of
follow-ups on the NT antibody titers of the
vaccinated children and given in Table 3. The
titers of the \, accinated cltildren witlT acute
ICUkemia persisted wcll
2. Pal'11',//n skill Irnc/107i I'll t, acci"tried childi e?I




at a1. , 1977) also became positive after vaccina-
tion in nTost vaccine recipients. 'I'he degree
of the skin reaction was rather \, ariable during
the period of observation depending upon the
status of cellular Immunity of these children
and on their chemotherapcutic treatmcnt. The
reaction was definitely POSitivc after cessation
of chemotherapy, that Is 3 years after initial
















Years alter variceila vaccination
FIGiiRE I. Percentage of vatccinated children with leukemia giving positive \. aricella skin reactions (stippled









































































TABI. E 5. Herpes-20ste, . lit let, hemic children













"," The same patient developed zoster twice
the percentage of cases giving more than one
positive reaction (erythematous change of 5-
10 mm in diameter) and the stippled column
shows the percentage of those giving two POSi-
tive reactions of more than 10 mm in diameter.
3. Protecti"e effect of uricci?,@ti'o71 agrii}1st con-
tact rayfectio, I
The efficacy of the \, accine was also judged
by whether vaccinated patients developed clini-
cal manifestation after exposure to cases of
vancella. As shown in Table 4, among a total
of 48 exposures of vaccinees to natural infoc-
tion, only 3 children (2 family, I classmate)









2) Naturally infected history (63 cases)
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toms were mild (20-30 rashes and fever for
one day), suggesting that the immunity induced
by, vaccination was effective in reducing their
s), inptoms.
4. litc!'dence of 20ste, . i?I oncci?rated childre, I
Table 5 shows a comparison of the inci-
dences of zoster in the vaccinated Ieukemic
children and in children who had experienced
natural varicella infection. Both groups had
received the same kind of chemotherapy.
There were 8 cases of zoster among 52 vac-
tinat, d children (15.4%) and ^in. rig 63 .hil-
drcn after natural varicella infection (17.5%).
11
12.5%
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